Remove 2016 Remove Compliance Remove DEA Remove State Laws
article thumbnail

DEA Promises Progress on Federal Cultivation Applications, But Provides No Timetable for Action

NORML

The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. In 2016, the DEA similarly announced the adoption of new rules to expand to supply of research-grade cannabis, but failed to take any further action.

DEA 162
article thumbnail

Marijuana as Schedule III: Woe is Me?

Canna Law Blog

Many people in the cannabis industry are convinced that this HHS recommendation to the Drug Enforcement Administration (DEA) means that the DEA will undertake this rescheduling (and fairly quickly, too–which would be a huge departure from its refusal to reschedule back in 2016). Just my two cents; feel free to disagree.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Guest Post: Is CBD Legal? Federal & State Laws [2019]

Cannabis Law Report

Although the DEA refuses to remove marijuana from the schedule 1 list, the Farm Bill is considered to be the most important victory in the history of U.S. Only CBD products produced in compliance with the Farm Bill would be legal by federal law. Unfortunately, no laws have been passed allowing individuals to distribute CBD.

article thumbnail

Document: Barr Responses To QFR’s: CLR Digs Out The Relevant Q’s & A’s

Cannabis Law Report

To expand the number of manufacturers, the Drug Enforcement Administration (DEA) submitted a notice in the Federal Register on August 11, 2016, soliciting applications for licenses to manufacture marijuana for research purposes. However, over two years have passed without any new schedule I marijuana manufacturer registrations.

article thumbnail

American Bar Association Urges Congress To Let States Set Their Own Marijuana Policies

SMPL

Though ABA specified that it was not taking a position on marijuana legalization generally, it recognized that conflicting federal and state cannabis policies are untenable and have created complications for cannabis businesses operating in compliance with state law.

Policy 40
article thumbnail

Hemp CBD Across State Lines: North Carolina

Canna Law Blog

General Assembly passed Senate Bill 313 in 2015, allowing the Industrial Hemp Commission to develop the rules and licensing structure necessary to stay within federal laws. The law was modified in 2016 in House Bill 992. The interim hemp rules require that hemp be tested 15-days prior to harvest.

Hemp 103
article thumbnail

McGuire Woods: In the Weeds: New Laws for 2022, Kansas Weighs Delta-8, Maine Appeals Dispensary Ruling, Nevada Approves Lounges

Cannabis Law Report

In The Weeds welcomes the new year, as well as a number of new cannabis laws and policies taking effect around the country in 2022. Below is a list of state law updates to look forward to this year. This DEA guidance and the Kansas opinion both suggest legality for some hemp-derived delta-8 products under the 0.3